CohBar, Inc. (CWBR) financial statements (2020 and earlier)

Company profile

Business Address 1455 ADAMS DRIVE, SUITE 2050
MENLO PARK, CA 94025
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13141720222428
Cash and cash equivalents131446914
Short-term investments 131315161614
Other undisclosed current assets0010000
Total current assets:13151720222428
Noncurrent Assets
Property, plant and equipment1000100
Intangible assets, net (including goodwill)0000000
Intangible assets, net (excluding goodwill)0000000
Other noncurrent assets0000000
Total noncurrent assets:1111100
TOTAL ASSETS:14151820232529
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2111212
Accounts payable0000101
Accrued liabilities1110000
Employee-related liabilities1001101
Total current liabilities:2111212
Noncurrent Liabilities
Other undisclosed noncurrent liabilities3333333
Total noncurrent liabilities:3333333
Total liabilities:5444544
Stockholders' equity
Stockholders' equity attributable to parent8111416182124
Common stock0000000
Additional paid in capital61606059585755
Accumulated deficit(53)(49)(46)(43)(40)(36)(31)
Total stockholders' equity:8111416182124
TOTAL LIABILITIES AND EQUITY:14151820232529

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Operating expenses(4)(3)(3)(3)(4)(4)(3)
Operating loss:(4)(3)(3)(3)(4)(4)(3)
Nonoperating expense(0)(0)(0)(0)(0)(0)(0)
Investment income, nonoperating0000000
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Net loss:(4)(3)(3)(3)(4)(5)(3)
Other undisclosed net income attributable to parent0000000
Net loss available to common stockholders, diluted:(4)(3)(3)(3)(4)(5)(3)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(4)(3)(3)(3)(4)(5)(3)
Comprehensive loss, net of tax, attributable to parent:(4)(3)(3)(3)(4)(5)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: